A groundbreaking development in diabetes treatment reveals that SGLT-2 inhibitors significantly reduce dementia risk among type 2 diabetes patients. Recent research demonstrates these medications ...

An international research team led by Professor Marc-Emmanuel Dumas at Imperial College London & CNRS together with Prof.

A team of scientists from the University of Sydney’s Charles Perkins Centre has discovered a previously unknown biological pathway that could explain why people with type 2 diabetes face a higher risk ...

The findings suggest that intranasally delivered FGF-1 may reverse type 2 diabetes by targeting dysfunctional glucose-sensing ...

PLEASANTON, Calif., Nov. 4, 2025 /PRNewswire/ -- Aqua Medical, a company advancing Endoscopic Metabolic Restoration for type 2 diabetes, today announced that the U.S. Food and Drug Administration (FDA ...

A clinical trial found that metformin, a drug typically used for type 2 diabetes, reduced insulin requirements by around 12% ...

The discovery, featured on the cover of Analytical Chemistry, could potentially slow the progression to full-blown diabetes.

A new DNA methylation-based blood test can identify type 2 diabetes patients at the highest risk of heart attack or stroke years in advance, beating traditional risk scores and opening the door to ...

Diabetes is no laughing matter According to data from the American Diabetes Association in 2012, some 29.1 million Americans have diabetes, most of whom have type 2 diabetes, which is the non-genetic ...

Dietitian Live has mapped a repeatable subconscious-to-physiology pathway showing that when belief shifts, the body heals. The company uncovered a consistent, client-partnered process for rewiring ...

Argentine scientists have identified a mechanism that allows pancreatic beta cells, which produce insulin, to become ...